source
- Sequencing antibody-drug conjugates adds complexity to recurrent endometrial cancer treatmentTherapy sequencing for recurrent endometrial cancer is becoming increasingly complex as immunotherapy moves earlier in the treatment pathway and antibody-drug conjugates (ADCs) gain traction. Expe…
- Experts highlight need for broader monitoring in polycythemia vera as patient shows disease progression despite controlled hematocritA 68-year‑old woman with a six‑year history of polycythemia vera (PV) and prior deep‑vein thrombosis has kept her hematocrit below 45% on hydroxyurea, indicating good control of that metric. Desp…